生物反应调节剂

结论：AbE有可能成为一种能改善造血与免疫功能的生物反应调节剂。

Conclusion : AbE is potentially a biological response modulator for hemopoietic and immuno-regulstion .

目的探讨顺铂（DDP）联合生物反应调节剂（BRM）治疗恶性胸腹腔积液的疗效。

Objective Toe value the effect of intracavity treatment with DDP and BRM for malignant pleural effusions or ascites .

匹多莫德（pidotimod）是一种新型的可剌激机体免疫活性的生物反应调节剂。

Pidotimod is a new biological response modifier ( BRM ) with immunomodulating activity .

生物反应调节剂与化疗药物对K-562白血病细胞系的体外协同作用

In vitro synergistic effects of BRMS in combination with chemotherapeutic drugs on K-562 leukemia cells

目的观察金葡素注射液（生物反应调节剂）与顺铂（抗肿瘤药）配伍对小鼠H22肝癌移植瘤的作用。

Objective To study on the effects of staphylococcal enterotoxin C injection ( SAFP ) combined with cisplatin injection on H22 liver cancer cells .

裂褶多糖（Schizophyllan）是一种生物反应调节剂，它在临床应用上表现出良好的抗肿瘤活性。

Schizophyllan is one kind of biological response modifiers . It shows good antitumor activity in clinical application .

目的观察顺铂（DDP）联合生物反应调节剂斯奇康（卡介菌多糖核酸注射液，BCGPSN）治疗恶性胸腔积液的疗效。

Objective To investigate the efficacy of the combination therapy of polysaccharide nucleic acid fraction of Bacillus Calmette-Guerin ( BCG-PSN ) plus cisplatin in the treatment of malignant pleural effusion .

目的：观察生物反应调节剂高聚金葡素（HighlyAgglutinativeStaphylococcin，HASL）加中药治疗中晚期恶性肿瘤的疗效。

Objective : To observe the effects of biological response agent ( highly agglutinative staphylococcin , HASL ) plused traditional Chinese medicinal herbs treatment in the advanced malignant tumours .

[结果]抗肿瘤药、生物反应调节剂和升白细胞药分别占全部药品年消耗总金额的2424%～3373%、1580%～2333%和586%～911%。化疗联合生物治疗对结肠癌患者IL-10的影响

Antineoplastics , biological response modifiers and leukogenics made up 24 24 % 33 73 % , 15 80 % 23 33 % and 5 86 % 9 11 % of total drug consumption respectively . The Influence of Chemotherapy and Biological Response Modifiers on IL-10 of Colon Cancer

心包腔内化疗联合生物反应调节剂治疗恶性心包积液的临床观察

Clinical observation of intrapericardial chemotherapy fot malignant peri - cardial effusion

生物反应调节剂（BRM－102）冲剂诱变和抗诱变作用的研究

Experimental study on the mutagenesis and antimutagenesis effect of biological response modifiers

目的沙培林是一种生物反应调节剂。

Objective Sapylin is one of the biological response modifiers .

光合细菌作为生物反应调节剂在肿瘤治疗中的作用研究

Study on the Effect of Photosynthetic Bacteria Used as a Biologic Response Modifier in Anti-tumor Therapy

简介了一种新的生物反应调节剂&S311菌苗的主要药理、药效学研究工作。

A new biological response modifier , S 311 vaccine , is introduced in this paper .

顺铂联合生物反应调节剂腔内治疗恶性胸腹腔积液

Intracavity Treatment with DDP and Biological Response Modifiers ( BRM ) for Malignant Pleural Effusions of Ascites

作为一种独特的生物反应调节剂，灰树花多糖具有极大的开发利用前景。

As a special biological response modifier , polysaccharide from Grifola frondosa has shown well perspective of utilization .

提示光合细菌可作为一种新的生物反应调节剂用于肿瘤治疗中。

These findings suggest that photosynthetic bacteria can be used as a new Biologic Response Modifier on Anti-tumor Therapy .

5-氟脲嘧啶、顺铂加生物反应调节剂配合外照射治疗Ⅱ期以上的鼻咽癌的临床研究

Preliminary study on nasopharyngeal carcinoma above ⅱ - stage treated by radiotherapy combined with cisplatin , 5-flurouracil plus biological response modifier

治疗手段主要包括微波消融、局部注射无水酒精、抗肿瘤生物反应调节剂等。

Therapeutic means include microwave ablation , percutaneous ethanol injection ( PEI ) and percutaneous injection of Gaojusheng therapies and so on .

还对分化诱导剂、拓扑异构酶抑制剂、抗微管药和生物反应调节剂的筛选方法进行了评述。

In addition , the paper reviewed screening methods for differentiation inducers , DNA topoisomerase inhibitors , antimicrotubule drugs and biological response modifiers .

目的观察化、放疗加生物反应调节剂（BiologicalresponsemodifierBRM）的综合治疗对Ⅱ期以上的鼻咽癌（NasopharygealCarcinomaNPC）的疗效。

Objective A prospective study was conducted to assess the preliminary results of chemo radiotherapy plus biological response modifier ( BRM ) for nasopharyngeal carcinoma ( NPC ) above ⅱ stage .

肿瘤的化疗是临床治疗的三大常规疗法之一，目前化疗已经发展成为包括烷化剂、抗代谢剂、分化诱导剂、生物反应调节剂等多个体系。

The chemotherapy of tumor is one the three general therapeutics in clinic therapy , now chemotherapy is developed into many systems which includes alkylating agent 、 antimetabolite 、 biologic response regulator .

结论：硒酸酯多糖是一种实用而有效的生物反应调节剂，肿瘤杀伤效应细胞＋化疗＋生物反应调节剂方案是一种白？

Conclusion : KSC is a hopeful biological response modifier in cancer biotherapy , and tumor killing effector cells and chemotherapy plus BRM might be a promising candidate for human leukemia biotherapy .

生物反应调节剂法作为近年来出现的一种新型的肿瘤治疗方法，因其较传统肿瘤治疗方法有许多优越之处，得到了普遍的重视，在临床治疗中也显示出良好的治疗效果。

As a new method of Anti-tumor Therapy , Biologic Response Modifier has many Characteristic advantages and is getting more attention now . And they have had some visible effects in clinical treatment .

另外，生物反应调节剂单一应用一般有效，同时亦可联合应用或者联合其他治疗手段综合治疗。

In addition , a single application of biological response modifiers is generally effective and different biological response modifiers can also be combined and the BRM also can be combined with other different treatments to treat tumors .

越来越多的临床治疗经验表明，联合生物反应调节剂、细胞毒药物或抗病毒药物可发掘干扰素的治疗潜能、减轻其副作用，但机制未明。

Clinic evidence showed that it would unearth therapy potential or lessen adverse effects of IFN - a in combination with biological regulators , cytotoxic agents or antivirus agents , but the exact mechanism was not known .

我们把改善患者机体与肿瘤关系的物质称为生物反应调节剂，生物反应调节剂与传统的细胞毒类药物不同，具有选择性强，毒性低，副作用小，而且一般无剂量依赖性等特点。

The materials which can improve the relationship between patient and tumor is called biological response modifier , and with high selectivity , low toxicity and small side effects and generally no dose-dependent characteristics , biological response modifiers are different from conventional cytotoxic drugs .

药用真菌作为药物，在我国已有几千年的历史，其中所含有的生物活性物质，尤其是多糖类物质，作为增强人体免疫功能的生物反应调节剂更是为人们所熟知。

Medicinal fungus has been used as a traditional Chinese medicine in China for several thousand years because of their various biological and pharmacological active ingredients , especially , polysaccharides . Recently , polysaccharides from medicinal fungus have been well-known as a potential Biological response modifier .